Table 1.
Initial therapeutic regimens
| Regimen | No. of patients |
|---|---|
| VCD | 19 |
| PAD | 8 |
| VDT PACE | 4 |
| VDT | 2 |
| MPV | 2 |
| VD | 3 |
| MPT | 2 |
| VAD | 6 |
| MP | 4 |
| ASCT | 16 |
| Double ASCT | 2 |
| Allo-SCT | 1 |
VCD cyclophosphamide, bortezomib, dexamethasone, VD bortezomib, dexamethasone, PAD bortezomib, adriamycin, dexamethasone, VDTPACE bortezomib, dexamethasone, thalidomide, cisplatinum, adriamycin, cyclophosphamide, etoposide, VDT bortezomib, dexamethasone, thalidomide, MPV melphalan, prednisone, bortezomib, VD bortezomib, dexamethasone, MPT melphalan, prednisone, thalidomide, VAD vincristine, adriamycin, dexamethasone, MP melphalan, prednisone, ASCT autologous stem-cell transplantation, Allo-SCT allogeneic stem cell transplantation